{"filings":[{"id":667999,"accession_number":"0001628280-26-038097","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2026-05-26T20:17:19+00:00","items":["5.02"],"status":"ready","headline":"UFP Technologies GC Christopher Litterio plans retirement after transition (notified May 19, 2026)","event_type":"leadership","confidence":"high","bullets":["Christopher P. Litterio, General Counsel, Secretary, and Senior Vice President of Human Resources, informed UFP Technologies on May 19, 2026 of his intention to retire after a transition period.","No specific retirement date or replacement has been announced.","He will remain with the company during the transition, per the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":99717,"accession_number":"0001628280-26-029906","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2026-05-04T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"UFP Technologies Q1 net income $17.5M, revenue up 4.1% to $154.2M","event_type":"earnings","confidence":"high","bullets":["GAAP EPS $2.24, adjusted EPS $2.48; net income up 1.8% YoY from $17.2M.","Medical sales grew 5.9% to $143.4M; non-medical fell 15% to $10.8M.","Robotic surgery (+7%), patient surfaces (+11%), interventional (+15%) led growth.","Two new Dominican Republic facilities in Q2 for robotic surgery and safe patient handling capacity.","Start-up costs for four ramping programs and AJR E-Verify labor inefficiencies weighed on margins."],"consensus_eps_estimate":null,"consensus_eps_actual":2.24,"consensus_revenue_estimate":null,"consensus_revenue_actual":154202000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.6,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":115880,"accession_number":"0001628280-26-012667","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2026-02-27T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"UFP Technologies files updated investor presentation; no material changes disclosed","event_type":"other","confidence":"low","bullets":["Filed 8-K furnishing updated investor presentation under Item 7.01.","Presentation dated March 2026; no specific financial or operational updates provided.","Intended for use in meetings with investors and other interested parties."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":115879,"accession_number":"0001628280-26-011154","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2026-02-24T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"UFP Tech extends supply pact with Intuitive Surgical to 2029, boosts min volumes","event_type":"other_material","confidence":"medium","bullets":["Amendment No. 27 extends Manufacturing Supply Agreement term by two years, now through Dec 31, 2029.","Materially increases annual minimum volumes for the Company's largest program under the agreement in 2028 and 2029.","Adds a new program to the Supply Agreement, expanding the scope of products supplied to Intuitive Surgical.","Includes volume-based pricing tied to minimum purchase thresholds and cost-sharing provisions; specific terms redacted as confidential.","WSUT's fleet of 22 PSVs (19 Brazilian-built) brings Tidewater's total global OSV fleet to 213 and expands Brazil presence to 28 vessels."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.7,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":115878,"accession_number":"0001628280-26-011152","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2026-02-24T23:59:59+00:00","items":["1.05"],"status":"ready","headline":"UFP Technologies detects cyber incident; data exfiltrated, systems mostly restored","event_type":"cyber","confidence":"high","bullets":["On Feb 14, 2026, UFP detected unauthorized access; third party removed and access restored in all material respects.","Incident impacted many IT systems, including billing and label making; operations continued across all material respects.","Certain company data appears stolen or destroyed; extent of sensitive or personal data exfiltration still under investigation.","Company expects insurance to reimburse significant portion of containment and remediation direct costs.","As of filing, incident not materially impacting financial systems, operations, or financial condition; investigation ongoing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":115877,"accession_number":"0001628280-26-011150","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2026-02-24T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"UFP Technologies reports record 2025 sales of $602.8M, EPS $8.75","event_type":"earnings","confidence":"high","bullets":["Net income $68.3M (+15.8% YoY); adjusted net income $76.1M (+12.7%).","Sales $602.8M (+19.5% YoY); medical sales up 23.2%, non-medical down 11.5%.","GAAP EPS $8.75; adjusted EPS $9.76 vs $8.68 in 2024.","Q4 sales $148.9M (+3.4%); Q4 GAAP EPS $2.25, adjusted $2.44.","AJR labor inefficiencies $6.3M full-year ($1.2M Q4); expects resolution."],"consensus_eps_estimate":null,"consensus_eps_actual":8.75,"consensus_revenue_estimate":null,"consensus_revenue_actual":602797000.0,"consensus_period":"2025-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":115876,"accession_number":"0001628280-26-008183","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2026-02-13T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"UFP Technologies appoints Mitchell C. Rock as CEO effective June 4, 2026; base salary $700k","event_type":"leadership","confidence":"high","bullets":["Mitchell C. Rock appointed CEO effective June 4, 2026; base salary $700k, annual bonus target up to 100% of base.","Rock receives one-time RSU grant of $650k (3yr vesting) and annual LTI target of $1.75M for 2026, increasing to $3M from 2027.","Executive severance agreement provides 18 months base salary for non-CIC termination, 2x (salary + bonus) plus equity acceleration for CIC termination within 6 months.","Board approved base salary increases for other NEOs: Lataille $505k, Litterio $400.5k, Holt $400k.","Retiring CEO Bailly receives $5.1M stock unit award fully vesting June 4, 2027, and his salary reduces to $600k as Executive Chairman."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":132293,"accession_number":"0001628280-25-054605","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2025-12-02T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"UFP Technologies posts updated investor presentation; no specific financial disclosures in excerpt","event_type":"other_material","confidence":"low","bullets":["Updated investor presentation (Exhibit 99.1) released for meetings starting December 2025.","Excerpt provided does not contain new financial data, guidance, or material business changes.","Presentation likely covers business strategy, but full details are not included in this filing text."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":132292,"accession_number":"0001628280-25-054603","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2025-12-02T23:59:59+00:00","items":["5.02","7.01","9.01"],"status":"ready","headline":"UFP Technologies CEO Bailly to retire June 2026; President Rock to succeed","event_type":"leadership","confidence":"high","bullets":["R. Jeffrey Bailly will retire as CEO effective June 4, 2026, after 31 years as CEO.","President Mitchell Rock will become CEO and join the Board on that date.","Bailly will serve as Executive Chairman for one year to facilitate transition.","Under Bailly, revenue grew ~20x, profitability and market cap grew >150x.","Rock has served as President since Feb 2024 and has 25+ years with the company."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":132291,"accession_number":"0001628280-25-048260","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2025-11-03T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"UFP Technologies Q3 EPS flat at $2.11; sales up 6.5% but organic sales flat due to labor issue","event_type":"earnings","confidence":"high","bullets":["Q3 net income $16.4M ($2.11 diluted EPS), flat YoY; adjusted EPS $2.39.","Sales $154.6M (+6.5% YoY); MedTech up 7.3% to $142.4M; non-medical down 2.7%.","Gross margin fell to 27.7% from 28.6% due to ~$3M incremental labor cost at Illinois AJR facility; absent that, would have been 29.6%.","Organic sales flat; over $8M in orders unfulfilled due to labor eligibility review at AJR; Q4 impact expected to be significantly less.","Two new robotic surgery programs on track for commercial production by year-end; CEO expects significant 2026+ revenue."],"consensus_eps_estimate":null,"consensus_eps_actual":6.52,"consensus_revenue_estimate":null,"consensus_revenue_actual":453882000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.55,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":148876,"accession_number":"0001171843-25-005547","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2025-08-21T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"UFP Technologies files updated investor presentation under Regulation FD","event_type":"other_material","confidence":"low","bullets":["Furnished investor presentation under Item 7.01; no financial results disclosed.","Presentation includes forward-looking statements; no specific guidance changes reported.","Ticker UFPT; no new material operational data available from filing excerpt."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":148875,"accession_number":"0001171843-25-005027","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2025-08-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"UFP Technologies Q2 2025: Record net income $17.2M; sales up 37% YoY; completed two acquisitions","event_type":"earnings","confidence":"high","bullets":["Net income of $17.2M ($2.21 diluted EPS) vs $13.6M ($1.75) in Q2 2024; adjusted EPS $2.50 (+27%).","Sales of $151.2M, up 37.2% YoY; organic growth 4.9%; MedTech +46%, Advanced Components -20%.","Gross margin 28.8% (down from 30.0%) from ~$1.2M labor costs at AJR facility due to E-Verify protocols.","Completed acquisitions of Universal Plastics & Engineering and Techno Plastics Industries in Q2.","Adjusted EBITDA $31.8M, up 33.2% YoY; YTD adjusted EBITDA $62.1M, up 39.1%."],"consensus_eps_estimate":null,"consensus_eps_actual":4.42,"consensus_revenue_estimate":null,"consensus_revenue_actual":151176000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":148874,"accession_number":"0001171843-25-004519","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2025-07-17T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"UFP Technologies acquires UNIPEC ($7.5M) and TPI ($4.5M) to expand medical device film and molding capabilities","event_type":"m_and_a","confidence":"high","bullets":["UNIPEC acquired for $7.5M cash; ~3.75x adj. EBITDA; $5M revenue, $2M EBITDA.","TPI acquired for $4.5M cash; ~4.5x adj. EBITDA; $10M revenue, $1M EBITDA.","Acquisitions expand thin film (UNIPEC) and thermoplastic molding (TPI) capabilities for implantable and surgical devices.","Funded with available cash and borrowings under existing credit facility.","Both companies serve Class III implantable medical device OEMs."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":167773,"accession_number":"0001171843-25-003809","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2025-06-10T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"UFP Technologies furnishes investor presentation; no material new data disclosed","event_type":"other_material","confidence":"low","bullets":["Presentation filed under Regulation FD for use in investor meetings.","No specific financial figures, guidance updates, or operational milestones provided.","Presentation appears to be an updated overview without material changes from prior communications."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":167772,"accession_number":"0001171843-25-003753","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2025-06-06T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"UFP Technologies reports annual meeting results; all director nominees elected and proposals approved","event_type":"other_material","confidence":"high","bullets":["Stockholders elected all seven director nominees; highest vote count for Symeria Hudson at 6,311,434 for.","Advisory vote on executive compensation passed with 5,684,666 for vs 799,852 against.","Advisory vote favored 1-year frequency for future say-on-pay votes (5,996,792 votes for 1 year).","Ratification of Grant Thornton LLP as auditor for 2025 approved with 6,445,924 for."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":167771,"accession_number":"0001171843-25-002859","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2025-05-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"UFP Technologies reports record Q1: revenue $148.1M (+41%), net income $17.2M (+35%), EPS $2.21","event_type":"earnings","confidence":"high","bullets":["Net sales $148.1M vs $105.0M (+41.1%); MedTech sales up 50.4% to $135.4M.","GAAP diluted EPS $2.21 vs $1.64; adjusted EPS $2.47 vs $1.77; adjusted EBITDA $30.2M (+45.9%).","MedTech organic growth 5.4% despite 6% Robotic Surgery decline; overall organic growth 2.3%.","Exclusive manufacturing agreement with second-largest customer for Safe Patient Handling through June 2030; Dominican Republic expansion.","Closed small fold-in acquisition (former sister company of AJR); balance sheet strengthened with debt paydown."],"consensus_eps_estimate":null,"consensus_eps_actual":2.21,"consensus_revenue_estimate":null,"consensus_revenue_actual":148148000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.75,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":167770,"accession_number":"0001171843-25-002025","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2025-04-04T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"UFP Technologies enters exclusive supply agreements with Stryker; manufacturing to move to Dominican Republic","event_type":"other_material","confidence":"high","bullets":["AJR Enterprises subsidiary signs two exclusive supply agreements with Sage Products (Stryker) for manufacturing rights.","March 31 agreement: 42-month exclusive term starting Jan 1, 2026; Stryker purchases 100% of requirements for certain products.","March 26 agreement amends prior deal: ~63-month term effective April 24, 2024, with similar exclusivity and manufacturing commitments.","UFP agrees to purchase equipment and transfer manufacturing to Dominican Republic over two years; Stryker provides payment for equipment.","Stryker may cease exclusivity if UFP fails regulatory/quality requirements; price reductions apply as production transfers."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":185044,"accession_number":"0001171843-25-001597","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2025-03-20T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"UFP Technologies' MedTech COO Steve Cardin resigns, effective March 28","event_type":"leadership","confidence":"high","bullets":["Steve Cardin, VP and COO of MedTech business, resigned effective March 28, 2025.","No replacement has been announced by the company.","No reason for the resignation was disclosed in the filing."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":185043,"accession_number":"0001171843-25-001061","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2025-02-25T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"UFP Technologies reports record 2024 revenue of $504.4M, adj. EPS $8.68, up 31%","event_type":"earnings","confidence":"high","bullets":["Full-year net income $59.0M (+31.3%); adjusted net income $67.6M (+32.5%); GAAP EPS $7.58, adj. EPS $8.68.","Q4 sales $144.1M (+41.9%); Q4 adj. net income $19.2M (+51.6%); Q4 adj. EPS $2.46.","MedTech sales grew 48.6% in Q4 and 30.2% for full year; gross margin improved to 29.1% from 28.1%.","Adjusted EBITDA for 2024 reached $107.3M, up 39.1% from $77.2M in 2023.","CEO cites acquisitions performing ahead, Dominican Republic expansion, and two major programs launching H2 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":7.58,"consensus_revenue_estimate":null,"consensus_revenue_actual":504421000.0,"consensus_period":"2024-FY","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":185042,"accession_number":"0001171843-25-000897","cik":914156,"company_name":"UFP TECHNOLOGIES INC","ticker":"UFPT","form_type":"8-K","filed_at":"2025-02-18T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"UFP Technologies approves FY2025 executive base salary increases and stock unit awards","event_type":"other_material","confidence":"high","bullets":["CEO Bailly base salary raised to $789,000; President Rock to $525,000; CFO Lataille to $485,000, effective Jan 1, 2025.","CEO Bailly granted 11,515 threshold stock units plus 5,758 target and 5,758 exceptional units.","CEO 2025 cash bonus target set at $828,450 (105% of base salary); max $1,656,900.","Other NEOs' cash bonus targets set at 40%-65% of base salary, with discretionary adjustment."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}